Search Results 791-800 of 17098 for treatment resistant depression

  1. Sumatriptan and naproxen (oral route) - Side effects & dosage - Mayo Clinic

    This especially includes medicines used to treat depression, including citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, olanzapine, paroxetine ...

  2. Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma - Mayo Clinic

    Participation eligibility · Diagnosis of CD30+ classical Hodgkin lymphoma reconfirmed by histopathology. · Relapsed or refractory disease after standard therapy ...

  3. Psychiatry and Psychology - Doctors - Mayo Clinic

    Allen, M.D.. Psychiatrist. Rochester, MN. Areas of focus: Electroconvulsive therapy, Delirium, Neurocognitive disorder, Depression, Anxiety disorder, Bipolar ...

  4. A Study to Evaluate the Effectiveness and Safety of Ibrexafungerp in Patients with Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment - Mayo Clinic

    About this study. The purpose of this study is to see how well study drug works at treating people with fungal diseases that are refractory to or intolerant of ...

  5. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...

  6. Hematology - Clinical trials

    The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

  7. Epilepsy - Doctors and departments - Mayo Clinic

    Diagnosis & treatmentCare at Mayo Clinic. Oct. 14, 2023. Print. Living ... drug-resistant epilepsy April 07, 2025, 02:16 p.m. CDT; (VIDEO) When seizures ...

  8. Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma. Print details. Share; Facebook · Twitter.

  9. Joel Streed | Mayo Clinic News Network - Page 68 of 170

    Kids and screen time / transcranial magnetic stimulation therapy for depression / oral cancer reconstruction: Mayo Clinic Radio. As summer vacation rolls on ...

  10. A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes - Mayo Clinic

    The purpose of Phase I of this study is to evaluate the safety and tolerability of CTX-712 in patients with relapsed/refractory (R/R) acute myeloid leukemia ( ...